A new artificial intelligence (AI) tool has demonstrated the ability to significantly enhance the diagnosis of Sjögren’s disease by…
Steve Bryson, PhD
Steve holds a PhD in biochemistry from the Faculty of Medicine at the University of Toronto, Canada. As a medical scientist for 18 years, he worked in both academia and industry, where his research focused on the discovery of new vaccines and medicines to treat inflammatory disorders and infectious diseases. Steve is a published author in multiple peer-reviewed scientific journals and a patented inventor.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Steve Bryson, PhD
Telitacicept safely and effectively eased disease activity in adults with primary Sjögren’s disease, according to data from a now-complete Phase…
Using stem cell eye drops — ones containing mesenchymal stem cells, or MSCs, which can give rise to other cell…
People with psoriasis, an autoimmune disorder marked by itchy, red patches of skin, appear to have…
Problems with regulatory T-cells, or Tregs — a type of immune cell that plays a key role in dampening the…
Topical application of the experimental therapy RCI001 prevented dry eye damage and improved tear secretion in a mouse model of…
The proteins CTSS and GSTO1 could accurately distinguish people with primary Sjögren’s syndrome from unaffected individuals, a study suggests,…
Adults with primary Sjögren’s syndrome (pSS) have a higher prevalence of common allergic disorders compared with those with rheumatoid…
A low dose treatment of interleukin-2 (IL-2), an immune signaling protein, improved salivary gland function in a Sjögren’s syndrome…
People with Sjögren’s syndrome are more likely to require inpatient hospital care for infections acquired in the community, especially…